Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.

Trial Profile

Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Milnacipran; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 03 Jul 2012 Actual initiation date changed from 25 Aug 2006 to 21 Nov 2006 as reported by EudraCT.
    • 03 Jul 2012 Planned End Date changed from 25 Feb 2008 to 21 Mar 2008 as reported by EudraCT.
    • 26 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top